Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 826

1.

Prognostic importance of sclerosing variant in papillary thyroid carcinoma.

Falvo L, Giacomelli L, D'Andrea V, Marzullo A, Guerriero G, de Antoni E.

Am Surg. 2006 May;72(5):438-44.

PMID:
16719201
2.

Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma.

Falvo L, Catania A, D'Andrea V, Marzullo A, Giustiniani MC, De Antoni E.

Ann Surg. 2005 Apr;241(4):640-6.

3.

Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution.

Fukushima M, Ito Y, Hirokawa M, Akasu H, Shimizu K, Miyauchi A.

World J Surg. 2009 May;33(5):958-62. doi: 10.1007/s00268-009-9940-6.

PMID:
19198928
4.

Prognostic factors of insular versus papillary/follicular thyroid carcinoma.

Falvo L, Catania A, D'Andrea V, Grilli P, D'Ercole C, De Antoni E.

Am Surg. 2004 May;70(5):461-6.

PMID:
15156957
5.
6.
7.

Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.

Kazaure HS, Roman SA, Sosa JA.

Ann Surg Oncol. 2012 Jun;19(6):1874-80. doi: 10.1245/s10434-011-2129-x. Epub 2011 Nov 8.

PMID:
22065195
8.

Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.

Thompson LD, Wieneke JA, Heffess CS.

Endocr Pathol. 2005 Winter;16(4):331-48.

PMID:
16627920
10.

Optimizing the treatment of AMES high-risk papillary thyroid carcinoma.

Lo CY, Chan WF, Lam KY, Wan KY.

World J Surg. 2004 Nov;28(11):1103-9.

PMID:
15490070
11.

Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.

Chang HY, Lin JD, Chou SC, Chao TC, Hsueh C.

Jpn J Clin Oncol. 2006 Nov;36(11):688-93. Epub 2006 Sep 25.

PMID:
17000702
12.

Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.

Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH.

Cancer. 2003 Jul 1;98(1):31-40.

14.

Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.

Lombardi CP, Bellantone R, De Crea C, Paladino NC, Fadda G, Salvatori M, Raffaelli M.

World J Surg. 2010 Jun;34(6):1214-21. doi: 10.1007/s00268-009-0375-x.

PMID:
20052467
15.

Papillary thyroid carcinoma in Kanazawa, Japan: prognostic significance of histological subtypes.

Mizukami Y, Noguchi M, Michigishi T, Nonomura A, Hashimoto T, Otakes S, Nakamura S, Matsubara F.

Histopathology. 1992 Mar;20(3):243-50.

PMID:
1563711
16.

[Differentiated thyroid carcinoma: prognostic factors].

Györy F, Lukács G, Nagy EV, Juhász F, Mezösi E, Szakáll S, Máth J, Balázs G.

Magy Seb. 2001 Apr;54(2):69-74. Hungarian.

PMID:
11339092
17.

Peroperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland.

Hamming JF, van de Velde CJ, Goslings BM, Fleuren GJ, Hermans J, Delemarre JF, van Slooten EA.

Surg Gynecol Obstet. 1989 Aug;169(2):107-14. Review.

PMID:
2667172
18.
19.

Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.

Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A.

Cancer. 2003 Mar 1;97(5):1181-5.

20.

[Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].

Lin YK, Sheng JM, Zhao WH, Wang WB, Yu XF, Teng LS, Ma ZM.

Zhonghua Wai Ke Za Zhi. 2009 Mar 15;47(6):450-3. Chinese.

PMID:
19595234

Supplemental Content

Support Center